Chemotherapy nave patients with unresectable MPM were stratified by histology and performance status , and randomized @:@ to pemetrexed/cisplatin plus CBP@ @mg/m ( @ ) IV ( Arm A ) or pemetrexed/cisplatin alone ( Arm B ) .